July 23, 2025

Stratified Antibiotic Approach Urged for cUTIs

A new guideline outlines stratified antibiotic treatment for complicated urinary tract infections, including shorter durations, oral transition timing, and tailored empiric choices based on illness severity and resistance risks.

Conexiant

July 21, 2025

Stanford Physician-Scientist Takes CDER Helm

Stanford's George Tidmarsh appointed FDA's new CDER director, bringing 30+ years biotechnology experience and seven approved drugs.

Conexiant

July 21, 2025

Sharp Rise in Fentanyl Overdoses During Pandemic

From 2019 to 2021, U.S. emergency departments saw a 125.4% rise in synthetic opioid overdoses, highlighting shifting trends in hospital use related to opioids during and before the COVID-19 pandemic.

Conexiant

July 01, 2025

Five Gynecologic Conditions Linked with Bladder Pain

A new international consensus identifies five gynecologic conditions commonly linked with interstitial cystitis/bladder pain syndrome, urging clinicians to adopt a multidisciplinary and trauma-informed approach to care.

Conexiant

June 24, 2025

Shorter Antibiotic Courses: Safe for DFO?

A new meta-analysis aims to clarify optimal antibiotic duration for diabetic foot osteomyelitis

Conexiant

June 24, 2025

FDA Approves At-Home Lupus Nephritis Therapy

The FDA has approved a subcutaneous autoinjector of belimumab for at-home treatment of pediatric lupus nephritis.

Conexiant

June 18, 2025

Are CBD Compounds Effective Antifungals?

CBD and CBDV exhibit antifungal activity against Cryptococcus neoformans and dermatophytes in vitro and improve survival in an in vivo model.

Conexiant